User Reviews for Macugen to treat Macular Degeneration
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Reviews for Macugen
Learn more about Macular Degeneration
IBM Watson Micromedex
Symptoms and treatments
ICD-10 CM Clinical Codes (External)
More about Macugen (pegaptanib ophthalmic)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: anti-angiogenic ophthalmic agents
- FDA Alerts (1)
- FDA Approval History
"Has significantly slowed the progression and even improved sight in my left eye. This last treatment however, has left my eyes feeling sore and I have a small floater. It has been 4 days since my treatment, this is why I am mentioning it. To anybody considering this treatment, I say, please do it - there are more benefits than risks."
Cardinal Mo August 9, 2015
3 users found this comment helpful.
Did you? Yes No | Report inappropriate